Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.
Vitetta
E S
ES
Cancer Immunobiology Center, University of Texas Southwestern Medical Center at Dallas 75235-8576.
Uhr
J W
JW
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000276:immunology; D051379:Mice; D008819:Mice, Nude; D016513:Mice, SCID; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D011971:Receptors, Immunologic / Q000276:immunology; D015398:Signal Transduction
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018719:Erb-b2 Receptor Tyrosine Kinases; D011971:Receptors, Immunologic